Exelixis
EXEL
#1546
Rank
NZ$25.07 B
Marketcap
NZ$101.21
Share price
1.55%
Change (1 day)
60.10%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company